JCIA
PTCT icon

Jackson Creek Investment Advisors’s PTC Therapeutics PTCT Stock Holding History

Jackson Creek Investment Advisors’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$901K Buy
+13,250
New +$957K 0.3% 157
2026
Q1 		– Sell
-22,603
Closed -$1.72M – 366
2025
Q4 		$1.72M Sell
22,603
-14,113
-38% -$1.03M 0.51% 80
2025
Q3 		$2.25M Sell
36,716
-13
-0% -$677 0.65% 28
2025
Q2 		$1.79M Buy
+36,729
New +$1.74M 0.48% 73

Other funds holding PTCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Toronto Dominion Bank
Toronto Dominion Bank Toronto, Ontario, Ontario, Canada $86.4B AUM 59.51% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

Jackson Creek Investment Advisors's PTCT Position: Q2 2026 in Review

Jackson Creek Investment Advisors opened a new position in PTC Therapeutics (PTCT) in Q2 2026: 13,250 shares worth $901K. The stake represents 0.3% of the portfolio and ranks #157 among its holdings. This is a return to the name: Jackson Creek Investment Advisors previously reported a position in PTCT as recently as Q4 2025.

Jackson Creek Investment Advisors first reported a position in PTCT in Q2 2025 and has held it in 4 quarters since. The position peaked at $2.25M in Q3 2025. 382 funds tracked by Wall St. Rank hold PTCT as of Q2 2026.

  • Jackson Creek Investment Advisors held 13,250 shares of PTC Therapeutics worth $901K as of Q2 2026.
  • PTC Therapeutics was a new Jackson Creek Investment Advisors position in Q2 2026.
  • PTC Therapeutics made up 0.3% of Jackson Creek Investment Advisors's portfolio in Q2 2026, its #157 holding.
  • Jackson Creek Investment Advisors first reported a position in PTC Therapeutics in Q2 2025 and has held it in 4 quarters since.
  • Jackson Creek Investment Advisors's PTC Therapeutics position peaked at $2.25M in Q3 2025.
  • 382 funds tracked by Wall St. Rank held PTC Therapeutics as of Q2 2026.

Based on Jackson Creek Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.